<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
</head>
<body><p style="text-align:justify;"><span >A stroke&nbsp;can be defined as a sudden global or focal neurological deficit resulting from spontaneous haemorrhage or infarction of the central nervous system, with objective evidence of an infarction or haemorrhage, irrespective of the duration of clinical symptoms. A CT or MRI&nbsp;scan&nbsp;is&nbsp;required to&nbsp;make&nbsp;the&nbsp;diagnosis&nbsp;and&nbsp;exclude&nbsp;other intracranial lesions that could present similarly.</span></p><p style="text-align:justify;"><span >A Transient Ischaemic Attack (TIA), on the other hand, is a transient episode of neurologic dysfunction caused by focal brain, spinal cord, or retinal ischemia. There is no objective evidence of acute infarction in the affected region of brain or retina.</span></p><p style="text-align:justify;"><span >In adults, hypertension, diabetes, dyslipidaemia, atrial fibrillation and smoking, increase the risk for strokes. In children sickle cell disease and cyanotic heart disease are important risk factors for strokes.</span></p><p style="text-align:justify;"><span >Patients should ideally have multidisciplinary care.</span></p><h3>CAUSES</h3><p>•&nbsp; Cerebral&nbsp;infarction:</p><ul><li>Thrombosis of a cerebral&nbsp;vessel</li><li>Embolism from a distant site (e.g. atrial&nbsp;fibrillation)</li></ul><p>•&nbsp; Intracerebral&nbsp;haemorrhage</p><p>•&nbsp; Subarachnoid&nbsp;haemorrhage</p><h3>SYMPTOMS</h3><p>•&nbsp; Weakness&nbsp;of&nbsp;one&nbsp;side&nbsp;of&nbsp;the&nbsp;body&nbsp;including the&nbsp;face</p><p>•&nbsp; Inability&nbsp;to&nbsp;rise&nbsp;up&nbsp;from&nbsp;a&nbsp;sitting&nbsp;or&nbsp;lying&nbsp;position</p><p>•&nbsp; Sudden&nbsp;fall/collapse</p><p>•&nbsp; Loss of&nbsp;speech</p><p>•&nbsp; Loss of&nbsp;vision</p><p>•&nbsp; Severe&nbsp;headache and/or&nbsp;neck&nbsp;pain&nbsp;(subarachnoid&nbsp;haemorrhage)</p><p>•&nbsp; Unconsciousness in some&nbsp;patients</p><p>•&nbsp; Seizures</p><h3>SIGNS</h3><p>•&nbsp; Paralysis of a&nbsp;limb</p><p>•&nbsp; Facial paralysis (lower&nbsp;half)</p><p>•&nbsp; Initial&nbsp;flaccidity&nbsp;of&nbsp;limbs,&nbsp;but&nbsp;later&nbsp;spasticity&nbsp;and&nbsp;exaggerated&nbsp;reflexes</p><p>•&nbsp; Hemianopia (loss of one-half of visual&nbsp;field)</p><p>•&nbsp; Hemi-anaesthesia&nbsp;(loss&nbsp;of&nbsp;sensation&nbsp;of&nbsp;one-half&nbsp;of&nbsp;body)</p><p>•&nbsp; Extensor plantar&nbsp;response</p><p>•&nbsp; Dysarthria/dysphasia (alteration of&nbsp;speech)</p><p>•&nbsp; Neck stiffness (in subarachnoid&nbsp;haemorrhage)</p><h3>INVESTIGATIONS</h3><p>•&nbsp; FBC,&nbsp;ESR</p><p>•&nbsp; Blood&nbsp;glucose</p><p>•&nbsp; Serum lipid&nbsp;profile</p><p>•&nbsp; Blood urea, electrolytes and&nbsp;creatinine</p><p>•&nbsp; Uric&nbsp;acid</p><p>•&nbsp; ECG</p><p>•&nbsp; CT scan/MRI of the&nbsp;head</p><p>•&nbsp; Chest X-ray&nbsp;</p><p><strong>TREATMENT&nbsp;</strong></p><p><strong>Treatment objectives</strong></p><p>•&nbsp; To&nbsp;limit the area of brain&nbsp;damage</p><p>•&nbsp; To&nbsp;protect patients from the dangers of unconsciousness and immobility</p><p>•&nbsp; To&nbsp;prevent&nbsp;aspiration</p><p>•&nbsp; To&nbsp;treat the underlying cause if&nbsp;possible</p><p>•&nbsp; To&nbsp;identify&nbsp;and&nbsp;manage&nbsp;modifiable&nbsp;risk&nbsp;factors&nbsp;(hypertension,&nbsp;high cholesterol, diabetes mellitus&nbsp;etc.)</p><p>•&nbsp; To&nbsp;institute measures to improve functional&nbsp;recovery</p><p>•&nbsp; To&nbsp;support and rehabilitate patients who survive with&nbsp;residual disability</p><p>•&nbsp; To&nbsp;minimise adverse effects of drug&nbsp;therapy</p><h3>Non-pharmacological treatment</h3><ul><li>Admit and monitor patient's vital signs and neurological signs frequently (4&nbsp;hourly)</li><li style="text-align:justify;">Establish adequate airway in unconscious&nbsp;patients</li><li style="text-align:justify;">Swallowing test in an upright position (use 10-15ml of water)</li><li style="text-align:justify;">Insert nasogastric tube as early as possible for feeding and medications in unconscious patients or those with swallowing difficulties to prevent&nbsp;aspiration</li><li style="text-align:justify;">Nurse in the lateral position with suctioning where&nbsp;necessary</li><li style="text-align:justify;">Elevate&nbsp;head&nbsp;of&nbsp;bed&nbsp;to&nbsp;30&nbsp;degrees&nbsp;to&nbsp;reduce&nbsp;intracranial pressure</li><li>Prevent pressure sores by regular turning (every 2 hours) in bed</li><li>Maintain adequate&nbsp;hydration</li><li style="text-align:justify;">Keep patient clean and dry by frequent use of bedpan/urine pot, diapers, condom catheter as required. Urethral catheter should be used only if absolutely necessary</li><li style="text-align:justify;">Start physiotherapy as soon as&nbsp;practicable</li></ul><h3 style="text-align:justify;">Pharmacological treatment</h3><p><span ><strong>A. Infarctive Strokes and&nbsp;TIAs&nbsp;</strong></span></p><p><span ><strong>1<sup>st</sup> Line Treatment Evidence Rating:&nbsp;[B]</strong></span></p><ul><li>Aspirin,&nbsp;oral,</li></ul><p><strong><u>Adults</u></strong></p><p>300 mg stat.</p><p><strong>Then</strong></p><p>75 mg daily</p><p><strong><u>Children</u></strong></p><p>16&nbsp;years; &nbsp;same as adult&nbsp;dose</p><p>&lt;&nbsp;16&nbsp;years; &nbsp;not&nbsp;recommended</p><h3>And</h3><ul><li>Atorvastatin,&nbsp;oral,</li></ul><p><strong><u>Adults</u></strong></p><p>40-80 mg daily</p><p><strong><u>Children</u></strong></p><p>Not recommended</p><h3>Or</h3><ul><li>Rosuvastatin,&nbsp;oral,</li></ul><p><strong><u>Adults</u></strong></p><p>20-40 mg daily</p><p><strong><u>Children</u></strong></p><p>Not recommended</p><h3><span >B. Haemorrhagic Stroke with evidence of cerebral oedema&nbsp;present</span></h3><p><span ><strong>1<sup>st</sup> Line Treatment Evidence Rating: [B]</strong></span></p><ul><li>Mannitol,&nbsp;IV,</li></ul><p><strong><u>Adults</u></strong></p><p>0.5-1 g/kg 6 hourly (up to 2 g/kg per dose)</p><p><strong><u>Children</u></strong></p><p>1 month-18 years; 0.5-1.5 g/kg <strong>Or&nbsp;</strong>2.5-7.5 ml/kg of 20% solution</p><p><span >(See treatment flowchart for acute medical management of stroke below)</span></p><h3><span >C. Control of co-morbidities (e.g. hypertension, diabetes&nbsp;etc.)</span></h3><p><span >(See appropriate sections)</span></p><h3>REFERRAL CRITERIA</h3><p style="text-align:justify;"><span >Patients with worsening symptoms and signs should be urgently referred for specialist evaluation and care. All stable patients with neurological deficits&nbsp;should&nbsp;be&nbsp;referred&nbsp;to&nbsp;a&nbsp;speech therapist,&nbsp;occupational therapist or physiotherapist as&nbsp;appropriate.</span></p>
    <p><strong> FLOWCHART</strong></p>
    <div style="width: 95vw;">
    <img src="https://osamfrimpong.github.io/stg_app_web/images/stroke_one.png" alt="Flowchart: Stroke" style="max-width: 100%;height: auto;margin: auto;">
    </div>
    <div style="width: 95vw;">
        <img src="https://osamfrimpong.github.io/stg_app_web/images/stroke_two.png" alt="Flowchart: Stroke" style="max-width: 100%;height: auto;margin: auto;">
        </div>
    <p><br /><strong>Table 7-3: Flowchart: Stroke</strong></p>
</body>
</html>
